BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun S, Xun G, Zhang J, Gao Y, Ge J, Liu F, Qian Q, Liu X, Tian Y, Sun Q, Wang Q, Wang X. An integrated approach for investigating pharmacodynamic material basis of Lingguizhugan Decoction in the treatment of heart failure. J Ethnopharmacol 2022;:115366. [PMID: 35551974 DOI: 10.1016/j.jep.2022.115366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Gao Y, Zhang J, Zhang H, Sun S, Su S, Kong D, Wang Q. Revealment study on the regulation of lipid metabolism by Lingguizhugan Decoction in heart failure treatment based on integrated lipidomics and proteomics. Biomed Pharmacother 2023;158:114066. [PMID: 36528915 DOI: 10.1016/j.biopha.2022.114066] [Reference Citation Analysis]
2 Xiang M, Zhao X, Lu Y, Zhang Y, Ding F, Lv L, Wang Y, Shen Z, Li L, Cui X. Modified Linggui Zhugan Decoction protects against ventricular remodeling through ameliorating mitochondrial damage in post-myocardial infarction rats. Front Cardiovasc Med 2022;9:1038523. [PMID: 36704451 DOI: 10.3389/fcvm.2022.1038523] [Reference Citation Analysis]
3 Zuo M, Tang T, Wang X, Gu J, Wang L, Chen J, Yao J, Li X, Zhou P, Huang J. Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-12. [DOI: 10.1155/2022/1149231] [Reference Citation Analysis]